Jeff Walsh, Nvelop Therapeutics CEO

Two ex-blue­bird lead­ers launch Nvel­op with $100M to tack­le the biggest prob­lem in gene edit­ing

Nvel­op Ther­a­peu­tics launched Tues­day with $100 mil­lion in seed fund­ing to ad­vance re­search from the gene edit­ing pi­o­neers David Liu and Kei­th Joung, as they …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.